Stay updated on DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.

Latest updates to the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page
- Check6 days agoChange DetectedFooter revision tag updated to Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added, and older notices including the funding-lapse message and 'Revision: v3.4.1' were removed. These are minor maintenance updates that do not affect study content or user actions on the page.SummaryDifference0.4%

- Check41 days agoChange DetectedNew top banner informs visitors about a lapse in government funding and NIH Clinical Center status with links for updates. The page revision is labeled v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page adds a glossary and makes minor metadata label updates (for example, Last Update Submitted that Met QC Criteria and No FEAR Act Data) along with a new revision tag (Revision: v3.4.0) replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check83 days agoChange DetectedThe study Locations section was updated to reflect new and reorganized sites (Connecticut, Michigan, Texas, Quebec, and A Coruna), with the page revision updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX401 in Adults With GSDIa: Safety & Dose Clinical Trial page.